(Q39324197)

11 September 2017

Total body and serum potassium during prolonged thiazide therapy for essential hypertension (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47997

7 April 2022

main subject

arterial hypertension

0 references

author name string

P. R. Wilkinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47997

7 April 2022

H. Issler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47997

7 April 2022

R. Hesp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47997

7 April 2022

E. B. Raftery

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47997

7 April 2022

language of work or name

English

0 references

publication date

1 April 1975

1 reference

11 September 2017

5 April 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=47997

full work available at URL

7 April 2022

https://api.elsevier.com/content/article/PII:S0140673675924320?httpAccept=text/xml

1 reference

10.1016/S0140-6736(75)92432-0

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)92432-0

https://api.elsevier.com/content/article/PII:S0140673675924320?httpAccept=text/plain

7 April 2022

1 reference

10.1016/S0140-6736(75)92432-0

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)92432-0

7 April 2022

1 reference

11 September 2017

1

1 reference

11 September 2017

7910

1 reference

11 September 2017

759-762

1 reference

Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

Potassium loss with thiazide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

Diuretics, potassium depletion, and carbohydrate intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

Body composition changes in hypertensive subjects on long-term oral diuretic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

Total-body potassium in hypertension patients during prolonged diuretic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

EFFECTS OF ORAL DIURETICS ON RAISED ARTERIAL PRESSURE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

The relationship between total body potassium and exchangeable body potassium measured at 24 hours and 44 hours after administration of 43K

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

Total body potassium in long-term frusemide therapy: is potassium supplementation necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

The long-term treatment of hypertension with thiazide diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

The consequences of potassium depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992432-0

7 January 2021

10.1016/S0140-6736(75)92432-0

Identifiers

DOI

1 reference

11 September 2017

1 reference